Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet

The Netherlands twin register biobank: A resource for genetic epidemiological studies

The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes

Plasma apolipoprotein CI protects against mortality from infection in old age

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice

ApoE plasma levels and risk of cardiovascular mortality in old age

Combined Association and Linkage Analysis Applied to the APOE Locus

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglycerides (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

Two-locus linkage analysis applied to putative quantitative trait loci for lipoprotein(a) levels

Safety of long-term consumption of plant sterol esters-enriched spread

Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/apoCI-knocked out mice

Job strain and risk indicators for cardiovascular disease in young female nurses

Apolipoprotein E*3-Leiden transgenic mice mode for hypolipidaemic drugs

Seasonal variation in low density lipoprotein oxidation and antioxidant status

Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine

Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients

Immunological discrimination between the human apolipoprotein E2(Arg158→Cys) and E3 isoforms